| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Moore Paul Andrew is a Chief Scientific Officer at Zymeworks Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | ZYME Zymeworks Inc. | Chief Scientific Officer | Sale+OE | 9,560 | $22.67 | $216,758.66 | -16.5% | +13.6% | - | |
| Jan 5, 2026 | ZYME Zymeworks Inc. | Chief Scientific Officer | Sale+OE | 20,110 | $25.10 | $504,698.66 | -21.9% | +1.4% | - | |
| Jan 6, 2025 | ZYME Zymeworks Inc. | Chief Scientific Officer | Sale+OE | 21,200 | $14.92 | $316,390.92 | -35.8% | -27.9% | +67.2% | |
| Jan 8, 2024 | ZYME Zymeworks Inc. | Chief Scientific Officer | Sale+OE | 9,799 | $10.79 | $105,698.70 | -36.5% | -16.6% | +24.0% |